Description: Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
Home Page: www.invizyne.com
IZTC Technical Analysis
750 Royal Oaks Drive
Monrovia,
CA
91016
United States
Phone:
626 415 1488
Officers
| Name | Title |
|---|---|
| Mr. Mohammad Hayat J.D. | Co-Founder, Chairman of the Board & President |
| Dr. Tyler Korman Ph.D. | Co-Founder & Vice President of Research |
| Dr. Paul Opgenorth Ph.D. | Co-Founder & Vice President of Development |
| Mr. Michael Heltzen | Chief Executive Officer |
| Mr. James U. Bowie Ph.D. | Founder & Independent Director |
| Mr. Fouad Nawaz | Vice President of Finance |
| Mr. Lasse H. Gorlitz | Vice President of Communications |
| Mr. Michael Burns | Executive Vice President of Energy Transition |
| Dr. Zachary Karl Ph.D. | VP & Head of Business Development |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2024-11-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 29 |